Medicare ACO Rules For Adopting New Drugs Could Follow D Model – PhRMA

Medicare accountable care organizations should be required to update their clinical guidelines to incorporate new treatments shortly after they are launched, the Pharmaceutical Research and Manufacturers of America suggests in June 6 comments to the Centers for Medicare and Medicaid Services.